Literature DB >> 30446888

Association Between the Interleukin-17 Gene Polymorphism -197G>A and the Risk of Prostate Cancer in a Galician Population.

N Aguín1, A Rodríguez-Alonso2, N López-Trigo3, I P Castuera4, J R Luis3, B Caeiro3.   

Abstract

A case-control study was carried out in which the role of the Single Nucleotide Polymorphism rs2275913 in the pathogenesis of prostate cancer was analysed for the first time. This polymorphism is located in -197 position of IL-17A gene and implies a A>G change. The sample consists of 433 Galician men, 241 of whom are prostate cancer patients and 192 are healthy men with no tumours. Besides the influence of this marker, directly involved in the inflammatory process, other variables that were described as prostate cancer risk factors were also studied: age, smoking and Body Mass Index (BMI). By the analysis of Odds Ratio (OR) (CI 95%) a protective effect of heterozygous genotype AG was observed in comparison with homozygous genotypes AA and GG. As regards other risk factors, a significant increased risk was observed in smokers homozygous between 10 and 32 pack-years (p = 0.032). Age and BMI show interesting patterns, but not significant ones. This study shows a possible link between the rs2275913 and the onset of PCa which could be influenced by age, BMI and above all, smoking.

Entities:  

Keywords:  Inflammation; Interleukin-17A (IL-17A); Prostate cancer (PCa); SNP

Year:  2018        PMID: 30446888     DOI: 10.1007/s12253-018-0537-y

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  48 in total

1.  IL-17A and IL-17F polymorphisms and gastric cancer risk: a meta-analysis.

Authors:  Z Li; Y Liu; D Cao; M Jiang; F Luo
Journal:  Genet Mol Res       Date:  2015-06-26

Review 2.  Prostate cancer and inflammation: the evidence.

Authors:  Karen S Sfanos; Angelo M De Marzo
Journal:  Histopathology       Date:  2012-01       Impact factor: 5.087

3.  Interleukin-10 [ATA] promoter haplotype and prostate cancer risk: a population-based study.

Authors:  Tanja Eder; Ramona Mayer; Uwe Langsenlehner; Wilfried Renner; Peter Krippl; Thomas C Wascher; Karl Pummer; Karin S Kapp
Journal:  Eur J Cancer       Date:  2006-12-19       Impact factor: 9.162

4.  Effect of interleukin-17A and interleukin-17F gene polymorphisms on the risk of gastric cancer in a Chinese population.

Authors:  Zhu Qinghai; Wang Yanying; Chen Yunfang; Zhang Xukui; Zhang Xiaoqiao
Journal:  Gene       Date:  2013-12-04       Impact factor: 3.688

5.  Association of IL-10 polymorphisms with prostate cancer risk and grade of disease.

Authors:  Jessica M Faupel-Badger; La Creis Renee Kidd; Demetrius Albanes; Jarmo Virtamo; Karen Woodson; Joseph A Tangrea
Journal:  Cancer Causes Control       Date:  2007-11-13       Impact factor: 2.506

6.  Analysis of the association of interleukin-17 gene polymorphisms with gastric cancer risk and interaction with Helicobacter pylori infection in a Chinese population.

Authors:  Xukui Zhang; Luming Zheng; Yinggang Sun; Xiaoqiao Zhang
Journal:  Tumour Biol       Date:  2013-11-12

7.  Correlation between Interleukin-17 gene polymorphism and gastric cancer susceptibility in Han Chinese population.

Authors:  L-J Yang; W Gao; J-Y Bai; X-K Zhang; X Han; Y-H Sun; L-L Zhang; M-M Zhang
Journal:  Eur Rev Med Pharmacol Sci       Date:  2016-04       Impact factor: 3.507

8.  Association analysis of rs2275913G>A and rs763780T>C interleukin 17 polymorphisms in Chinese women with cervical cancer.

Authors:  L X Sun; X B Wang; X J Huang
Journal:  Genet Mol Res       Date:  2015-10-29

9.  IL-17F gene polymorphism is associated with susceptibility to acute myeloid leukemia.

Authors:  Tomasz Wróbel; Katarzyna Gębura; Barbara Wysoczańska; Bożena Jaźwiec; Olga Dobrzyńska; Grzegorz Mazur; Kazimierz Kuliczkowski; Katarzyna Bogunia-Kubik
Journal:  J Cancer Res Clin Oncol       Date:  2014-05-03       Impact factor: 4.553

10.  Association between IL17 polymorphisms and risk of cervical cancer in Chinese women.

Authors:  Yi Quan; Bin Zhou; Yanyun Wang; Ruiqi Duan; Kana Wang; Qianqian Gao; Shaoqing Shi; Yaping Song; Lin Zhang; Mingrong Xi
Journal:  Clin Dev Immunol       Date:  2012-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.